Clinique Universitaires Saint-Luc

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Epilepsy1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial
• Triple-negative breast cancer1 trial
• Type 1 diabetes1 trial

Phase

• Phase 1/21 trial

Status

• Recruiting3 trials

Lead sponsor

• Cliniques universitaires Saint-Luc- Université Catholique de Louvain2 trials
• Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

  NCT05985655· Phase 1/2· Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.· Source

  Contact: Rachel Galot (principal investigator)

• Recruiting

  Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

  NCT06770621· Cliniques universitaires Saint-Luc- Université Catholique de Louvain· Source

  Contact: Philippe Lysy, Pr

• Recruiting

  Identification of Biomarkers for Vagus Nerve Stimulation in Patients With Refractory Epilepsy

  NCT07909486· Cliniques universitaires Saint-Luc- Université Catholique de Louvain· Source

  Contact: Riëm EL TAHRY, Pr.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 1 diabetes1 recruiting